Literature DB >> 33257424

Early Adaptation of Colorectal Cancer Cells to the Peritoneal Cavity Is Associated with Activation of "Stemness" Programs and Local Inflammation.

Jorge Barriuso1,2,3, Raghavendar T Nagaraju4,2, Shreya Belgamwar4, Bipasha Chakrabarty4,5, George J Burghel6, Helene Schlecht6, Lucy Foster7, Elaine Kilgour8, Andrew J Wallace6, Michael Braun4,2,3, Caroline Dive8, D Gareth Evans9, Robert G Bristow10, Mark P Saunders4,11, Sarah T O'Dwyer4,2, Omer Aziz1,2.   

Abstract

PURPOSE: At diagnosis, colorectal cancer presents with synchronous peritoneal metastasis in up to 10% of patients. The peritoneum is poorly characterized with respect to its superspecialized microenvironment. Our aim was to describe the differences between peritoneal metastases and their matched primary tumors excised simultaneously at the time of surgery. Also, we tested the hypothesis of these differences being present in primary colorectal tumors and having prognostic capacity. EXPERIMENTAL
DESIGN: We report a comprehensive analysis of 30 samples from peritoneal metastasis with their matched colorectal cancer primaries obtained during cytoreductive surgery. We tested and validated the prognostic value of our findings in a pooled series of 660 colorectal cancer primary samples with overall survival (OS) information and 743 samples with disease-free survival (DFS) information from publicly available databases.
RESULTS: We identified 20 genes dysregulated in peritoneal metastasis that promote an early increasing role of "stemness" in conjunction with tumor-favorable inflammatory changes. When adjusted for age, gender, and stage, the 20-gene peritoneal signature proved to have prognostic value for both OS [adjusted HR for the high-risk group (vs. low-risk) 2.32 (95% confidence interval, CI, 1.69-3.19; P < 0.0001)] and for DFS [adjusted HR 2.08 (95% CI, 1.50-2.91; P < 0.0001)].
CONCLUSIONS: Our findings indicated that the activation of "stemness" pathways and adaptation to the peritoneal-specific environment are key to early stages of peritoneal carcinomatosis. The in silico analysis suggested that this 20-gene peritoneal signature may hold prognostic information with potential for development of new precision medicine strategies in this setting. ©2020 American Association for Cancer Research.

Entities:  

Mesh:

Year:  2020        PMID: 33257424      PMCID: PMC7611320          DOI: 10.1158/1078-0432.CCR-20-3320

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  32 in total

1.  Perivascular human endometrial mesenchymal stem cells express pathways relevant to self-renewal, lineage specification, and functional phenotype.

Authors:  Trimble L B Spitzer; Angela Rojas; Zara Zelenko; Lusine Aghajanova; David W Erikson; Fatima Barragan; Michelle Meyer; John S Tamaresis; Amy E Hamilton; Juan C Irwin; Linda C Giudice
Journal:  Biol Reprod       Date:  2012-02-29       Impact factor: 4.285

Review 2.  Peritoneal carcinomatosis of colorectal origin: incidence and current treatment strategies.

Authors:  Manuel J Koppe; Otto C Boerman; Wim J G Oyen; Robert P Bleichrodt
Journal:  Ann Surg       Date:  2006-02       Impact factor: 12.969

3.  Prognosis of patients with peritoneal metastatic colorectal cancer given systemic therapy: an analysis of individual patient data from prospective randomised trials from the Analysis and Research in Cancers of the Digestive System (ARCAD) database.

Authors:  Jan Franko; Qian Shi; Jeffrey P Meyers; Timothy S Maughan; Richard A Adams; Matthew T Seymour; Leonard Saltz; Cornelis J A Punt; Miriam Koopman; Christophe Tournigand; Niall C Tebbutt; Eduardo Diaz-Rubio; John Souglakos; Alfredo Falcone; Benoist Chibaudel; Volker Heinemann; Joseph Moen; Aimery De Gramont; Daniel J Sargent; Axel Grothey
Journal:  Lancet Oncol       Date:  2016-10-12       Impact factor: 41.316

4.  Expression of thrombospondin-1 in resected colorectal liver metastases predicts poor prognosis.

Authors:  Christopher D Sutton; Kenneth O'Byrne; Jonathan C Goddard; Leslie-Jayne Marshall; Louise Jones; Giuseppe Garcea; Ashley R Dennison; Graham Poston; David M Lloyd; David P Berry
Journal:  Clin Cancer Res       Date:  2005-09-15       Impact factor: 12.531

5.  Leukocytes recruited by tumor-derived HMGB1 sustain peritoneal carcinomatosis.

Authors:  Lucia Cottone; Annalisa Capobianco; Chiara Gualteroni; Antonella Monno; Isabella Raccagni; Silvia Valtorta; Tamara Canu; Tiziano Di Tomaso; Angelo Lombardo; Antonio Esposito; Rosa Maria Moresco; Alessandro Del Maschio; Luigi Naldini; Patrizia Rovere-Querini; Marco E Bianchi; Angelo A Manfredi
Journal:  Oncoimmunology       Date:  2016-01-08       Impact factor: 8.110

Review 6.  p75NTR is positively promiscuous: novel partners and new insights.

Authors:  Philip A Barker
Journal:  Neuron       Date:  2004-05-27       Impact factor: 17.173

7.  PROGgeneV2: enhancements on the existing database.

Authors:  Chirayu Pankaj Goswami; Harikrishna Nakshatri
Journal:  BMC Cancer       Date:  2014-12-17       Impact factor: 4.430

8.  Biomarker concordance between primary colorectal cancer and its metastases.

Authors:  D S Bhullar; J Barriuso; S Mullamitha; M P Saunders; S T O'Dwyer; O Aziz
Journal:  EBioMedicine       Date:  2019-02-04       Impact factor: 8.143

Review 9.  Wnt signaling in cancer stem cells and colon cancer metastasis.

Authors:  Sayon Basu; Gal Haase; Avri Ben-Ze'ev
Journal:  F1000Res       Date:  2016-04-19

10.  The consensus molecular subtypes of colorectal cancer.

Authors:  Justin Guinney; Rodrigo Dienstmann; Xin Wang; Aurélien de Reyniès; Andreas Schlicker; Charlotte Soneson; Laetitia Marisa; Paul Roepman; Gift Nyamundanda; Paolo Angelino; Brian M Bot; Jeffrey S Morris; Iris M Simon; Sarah Gerster; Evelyn Fessler; Felipe De Sousa E Melo; Edoardo Missiaglia; Hena Ramay; David Barras; Krisztian Homicsko; Dipen Maru; Ganiraju C Manyam; Bradley Broom; Valerie Boige; Beatriz Perez-Villamil; Ted Laderas; Ramon Salazar; Joe W Gray; Douglas Hanahan; Josep Tabernero; Rene Bernards; Stephen H Friend; Pierre Laurent-Puig; Jan Paul Medema; Anguraj Sadanandam; Lodewyk Wessels; Mauro Delorenzi; Scott Kopetz; Louis Vermeulen; Sabine Tejpar
Journal:  Nat Med       Date:  2015-10-12       Impact factor: 53.440

View more
  3 in total

1.  Consensus molecular subtype differences linking colon adenocarcinoma and obesity revealed by a cohort transcriptomic analysis.

Authors:  Michael W Greene; Peter T Abraham; Peyton C Kuhlers; Elizabeth A Lipke; Martin J Heslin; Stanley T Wijaya; Ifeoluwa Odeniyi
Journal:  PLoS One       Date:  2022-05-13       Impact factor: 3.752

2.  Peritoneal metastases from colorectal cancer belong to Consensus Molecular Subtype 4 and are sensitised to oxaliplatin by inhibiting reducing capacity.

Authors:  Jamila Laoukili; Alexander Constantinides; Emma C E Wassenaar; Sjoerd G Elias; Danielle A E Raats; Susanne J van Schelven; Jonathan van Wettum; Richard Volckmann; Jan Koster; Alwin D R Huitema; Simon W Nienhuijs; Ignace H J T de Hingh; René J Wiezer; Helma M U van Grevenstein; Inne H M Borel Rinkes; Djamila Boerma; Onno Kranenburg
Journal:  Br J Cancer       Date:  2022-02-22       Impact factor: 9.075

3.  A Prediction Model Intended for Exploratory Laparoscopy Risk Stratification in Colorectal Cancer Patients With Potential Occult Peritoneal Metastasis.

Authors:  Yuanxin Zhang; Xiusen Qin; Yang Li; Xi Zhang; Rui Luo; Zhijie Wu; Victoria Li; Shuai Han; Hui Wang; Huaiming Wang
Journal:  Front Oncol       Date:  2022-07-13       Impact factor: 5.738

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.